Are you dealing with permanent or persistent hair loss?
- Other options were available that did not have this side effect and women were not informed of them.
- Permanent and/or persistent hair loss can have harmful psychological effects on women.
- We can help you find out if you took Taxotere and we want to stop this from happening to other women. Call (800) 220-9341 or complete the form to the right to tell us your story.
Types of Alopecia Induced by Taxotere
According to recent litigation, Sanofi-Aventis only began to warn U.S. patients of the risk of permanent alopecia after being mandated to do so by the Food and Drug Administration (FDA) in December 2015, even though patients outside of the U.S. were warned about permanent hair loss as early as 2005. This means that because U.S. doctors and patients were unaware of Taxotere’s risk of permanent alopecia, the option of using an alternative chemotherapy drug that is as effective as Taxotere, but without its permanent side effects, was rarely used. During chemotherapy, hair loss is a well-known symptom, but is expected to grow back within 3-6 months of stopping treatment. Approximately 10-15% of women who used Taxotere during the course of treatment reported no hair growth for as long as ten years after stopping treatment. Alopecia can come in many different forms, including:
- Non-existent hair growth under arms or around genitals
- Lack of eyelashes
- Lack of eyebrows
- Total hair loss on both the scalp and body
Absolute hair loss on the scalp and body is a special form of alopecia called alopecia universalis, and is the most frequent hair loss condition reported with Taxotere use.
While chemotherapy drugs are expected to eradicate or slow the growth of cancer cells without any risk of permanent side effects, recent lawsuits from women across the country allege that one of the most widely used chemotherapy drugs in the U.S. is causing permanent hair loss, or alopecia, in unsuspecting cancer patients. While frequently used on women suffering from breast cancer, all types of cancer sufferers are placed at a higher risk of persistent alopecia if they have been treated with pharmaceutical conglomerate Sanofi-Aventis’ drug, Taxotere. Taxotere is a popular chemotherapy drug that has prominently been used to treat advanced or metastasized breast cancer. Estimates show that approximately 75% of women who have, or formerly had, breast cancer were treated with Taxotere under doctor’s recommendations without being warned of the significantly increased chance of suffering permanent hair loss. Lawsuits allege that the drug’s manufacturers knew about the possibility of permanent alopecia in users as early as the 1990s, yet deliberately concealed it to downplay the risks associated with Taxotere.
Additionally, statements from a company whistleblower allege that by taking advantage of vulnerable women’s lack of knowledge about the drug and incentivizing doctors with “kickbacks” to prescribe the drug, Sanofi-Aventis was able to significantly increase Taxotere revenue from $424 million in 2000 to $1.2 billion in 2004. Recent lawsuits also beg the question of why breast cancer patients were not recommended similar drugs on the market that did not have a risk of persistent alopecia, as the existence of alternative chemotherapy drugs that were at least as—if not more—effective than Taxotere has been long established.
After a hard-fought battle with cancer, suffering permanent hair loss from taking a drug you expected to heal you can feel like a series of compounding devastations. If you are now experiencing permanent hair loss after being urged to take Taxotere as a part of your breast cancer treatment, our Taxotere lawyers understand your frustration and anguish at being deceived by a multi-billion dollar pharmaceutical company. Permanent baldness in women can lead to a loss of enjoyment of life, additional medical expenses, psychological damage, and lost wages for cancer survivors who only wish to return to a normal life. The legal team at Williams Hart is fully prepared to fight against deceptive pharmaceutical companies on behalf of breast cancer survivors suffering permanent Taxotere-related hair loss.
Contact a Taxotere Attorney
After surviving a cancer diagnosis, it can be heartbreaking to suffer permanent hair loss because of a pharmaceutical company’s underhanded attempts to bury the public’s awareness of adverse side effects. Our Taxotere attorneys want to fight for the women who were blindsided by Sanofi-Aventis’ deceptive tactics, and must now face life-long consequences as a result. If you or someone you know has permanent alopecia after using Taxotere, Williams Hart may be able to help you hold the responsible parties accountable. Call our offices at (800) 220-9341 today to discuss your case.